Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) FCF Margin (2016 - 2020)

Syndax Pharmaceuticals (SNDX) has 6 years of FCF Margin data on record, last reported at 4113.42% in Q4 2020.

  • For Q4 2020, FCF Margin fell 76421.0% year-over-year to 4113.42%; the TTM value through Sep 2021 reached 22949.74%, down 1844374.0%, while the annual FY2025 figure was 187.5%, 97340.0% up from the prior year.
  • FCF Margin reached 4113.42% in Q4 2020 per SNDX's latest filing, up from 4827.7% in the prior quarter.
  • Across five years, FCF Margin topped out at 1069.91% in Q4 2017 and bottomed at 5648.28% in Q2 2020.
  • Average FCF Margin over 5 years is 3715.02%, with a median of 3915.61% recorded in 2017.
  • Peak YoY movement for FCF Margin: skyrocketed 2127375bps in 2016, then plummeted -289246bps in 2018.
  • A 5-year view of FCF Margin shows it stood at 3415.08% in 2016, then surged by 69bps to 1069.91% in 2017, then crashed by -270bps to 3962.37% in 2018, then rose by 15bps to 3349.21% in 2019, then fell by -23bps to 4113.42% in 2020.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 4113.42% in Q4 2020, 4827.7% in Q3 2020, and 5648.28% in Q2 2020.